Cargando…

The effect of exercise on IL-6-induced cachexia in the Apc(Min/+) mouse

BACKGROUND: Cachexia involves unintentional body weight loss including diminished muscle and adipose tissue mass and is associated with an underlying disease. Systemic overexpression of IL-6 accelerates cachexia in the Apc(Min/+) mouse, but does not induce wasting in control C57BL/6 mice. With many...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puppa, Melissa J., White, James P., Velázquez, Kandy T., Baltgalvis, Kristen A., Sato, Shuichi, Baynes, John W., Carson, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374019/ https://www.ncbi.nlm.nih.gov/pubmed/22476915 http://dx.doi.org/10.1007/s13539-011-0047-1

Ejemplares similares

IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc(Min/+) mouse
por: White, James P, et al.
Publicado: (2012)

Characterization of the male Apc(Min/+) mouse as a hypogonadism model related to cancer cachexia
por: White, James P., et al.
Publicado: (2013)

The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the Apc(Min/+) Mouse
por: White, James P., et al.
Publicado: (2011)

Liver Inflammation and Metabolic Signaling in Apc(Min/+) Mice: The Role of Cachexia Progression
por: Narsale, Aditi A., et al.
Publicado: (2015)

Platelet status in cancer cachexia progression in Apc(Min/+) mice
por: Cunningham, Patrice, et al.
Publicado: (2023)

Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in Apc(Min/+) mice
por: Narsale, Aditi A., et al.
Publicado: (2016)

The Effect of Estradiol Administration on Muscle Mass Loss and Cachexia Progression in Female Apc(Min/+) Mice
por: Counts, Brittany R., et al.
Publicado: (2019)

Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the Apc(Min/+) mouse
por: MANNE, NANDINI D.P.K., et al.
Publicado: (2013)

HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apc(min/+) mice
por: Tanaka, Hiromitsu, et al.
Publicado: (2019)

Exercise effects on polyp burden and immune markers in the Apc(Min)(/+) mouse model of intestinal tumorigenesis
por: McCLELLAN, JAMIE L., et al.
Publicado: (2014)

Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc(Min/+) mice
por: He, Zhengxiang, et al.
Publicado: (2017)

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2017)

Baoyuan Jiedu decoction alleviating cancer cachexia–Induced muscle atrophy by regulating muscle mitochondrial function in Apc ( Min/+ ) mice
por: Zhang, Beiying, et al.
Publicado: (2022)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

A semi-automated technique for adenoma quantification in the Apc(Min) mouse using FeatureCounter
por: Shepherd, Amy L., et al.
Publicado: (2020)

Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APC(MIN) Mouse Model
por: Asadi, Khalid, et al.
Publicado: (2017)

Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC(+/min) Mouse Model
por: Leko, Vid, et al.
Publicado: (2013)

Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC(Min/+) Mouse Model of Intestinal Tumorigenesis
por: Paul-Clark, Mark, et al.
Publicado: (2016)

Lactonic Sophorolipids Increase Tumor Burden in Apc(min+/-) Mice
por: Callaghan, Breedge, et al.
Publicado: (2016)

Metabolomics of Apc( Min/+ ) mice genetically susceptible to intestinal cancer
por: Dazard, Jean-Eudes J, et al.
Publicado: (2014)

Spontaneous Intestinal Tumorigenesis in Apc (/Min+) Mice Requires Altered T Cell Development with IL-17A
por: Chae, Wook-Jin, et al.
Publicado: (2015)

Reduction in the resident intestinal myelomonocytic cell population occurs during Apc(Min/+) mouse intestinal tumorigenesis
por: Faluyi, Olusola O., et al.
Publicado: (2021)

Increased variability in Apc(Min)/+ intestinal tissue can be measured with microultrasound
por: Fatehullah, A., et al.
Publicado: (2016)

Exercise through Shaking Stimuli Suppresses Cancer Growth via the Wnt pathway in Apc(Min/+) Mice
por: Iwata, Daiki, et al.
Publicado: (2023)

ERK activation drives intestinal tumorigenesis in Apc(min/)(+) mice
por: Lee, Sung Hee, et al.
Publicado: (2010)

OGA heterozygosity suppresses intestinal tumorigenesis in Apc(min/+) mice
por: Yang, Y R, et al.
Publicado: (2014)

Intestinal Peyer’s patches prevent tumorigenesis in Apc(Min/+) mice
por: Fujimoto, Kyoko, et al.
Publicado: (2015)

A novel cancer immunotherapy using tumor-infiltrating B cells in the APC(min/+) mouse model
por: Wang, Xinying, et al.
Publicado: (2021)

Mouse skeletal muscle adaptations to different durations of treadmill exercise after the cessation of FOLFOX chemotherapy
por: Halle, Jessica L., et al.
Publicado: (2023)

Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+ )mice and azoxymethane/dextran sulfate sodium-treated mice
por: Ju, Jihyeung, et al.
Publicado: (2008)

Therapeutic utility of aspirin in the Apc(Min/+) murine model of colon carcinogenesis
por: Reuter, Brian K, et al.
Publicado: (2002)

Chemopreventive effects of berberine on intestinal tumor development in Apc(min/+) mice
por: Cao, Hailong, et al.
Publicado: (2013)

Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice
por: Liu, W, et al.
Publicado: (2016)

Dietary Uridine Decreases Tumorigenesis in the Apc(Min/+) Model of Intestinal Cancer
por: Field, Martha S, et al.
Publicado: (2018)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

Transition state analogue of MTAP extends lifespan of APC(Min/+) mice
por: Firestone, Ross S., et al.
Publicado: (2021)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice
por: Caldwell, Christine M., et al.
Publicado: (2007)

Malic Enzyme 1 (ME1) is pro-oncogenic in Apc(Min/+) mice
por: Fernandes, Lorenzo M., et al.
Publicado: (2018)

Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc(Min/+) mouse model of intestinal tumorigenesis
por: Hull, Mark A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c4qa1fqls29cthl7k8oqtdqr2t